 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$5.27 |
$5.76 |
$5.18 |
$5.56 |
287.30K | | 04/17/2024 |
$5.55 |
$5.67 |
$5.09 |
$5.11 |
126.10K | | 04/18/2024 |
$5.04 |
$5.06 |
$4.72 |
$4.72 |
119.50K | | 04/19/2024 |
$4.67 |
$4.72 |
$4.40 |
$4.54 |
262.90K | | 04/22/2024 |
$4.57 |
$5.03 |
$4.57 |
$4.99 |
152.00K |
|
|
| Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical stage pipeline of gene control medicines. Co.'s primary product candidates are: Tamibarotene, which is a selective retinoic acid receptor alpha agonist that is being evaluated in combination with azacitidine; SY-2101, which is an oral form of arsenic trioxide; and SY-5609, which is a selective oral inhibitor of cyclin-dependent kinase 7 that is being evaluated in combination with chemotherapy in relapsed/refractory metastatic pancreatic cancer patients. | |
|
Syros Pharmaceuticals (SYRS) has the following price history information. Looking back at SYRS historical stock prices for the last five trading days, on April 16, 2024, SYRS opened at $5.27, traded as high as $5.76 and as low as $5.18, and closed at $5.56. Trading volume was a total of 287.30K shares. On April 17, 2024, SYRS opened at $5.55, traded as high as $5.67 and as low as $5.09, and closed at $5.11. Trading volume was a total of 126.10K shares. On April 18, 2024, SYRS opened at $5.04, traded as high as $5.06 and as low as $4.72, and closed at $4.72. Trading volume was a total of 119.50K shares. On April 19, 2024, SYRS opened at $4.67, traded as high as $4.72 and as low as $4.40, and closed at $4.54. Trading volume was a total of 262.90K shares. On April 22, 2024, SYRS opened at $4.57, traded as high as $5.03 and as low as $4.57, and closed at $4.99. Trading volume was a total of 152.00K shares.
SYRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Syros Pharmaceuticals shares, starting with a $10,000 purchase of SYRS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/01/2016 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$193.50 |
|
| End price/share: |
$4.99 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-97.42% |
|
| Average Annual Total Return: |
-37.38% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$257.97 |
|
| Years: |
7.81 |
|
|
|
| Date |
Close |
| 04/16/2024 | $5.56 | | 04/17/2024 | $5.11 | | 04/18/2024 | $4.72 | | 04/19/2024 | $4.54 | | 04/22/2024 | $4.99 |
|
|
Free SYRS Email Alerts:
